Stock listing

GPW:SVE SYNTHAVERSE Spolka Akcyjna Akcje

Home listing (GPW) of SYNTHAVERSE Spolka Akcyjna

Follow SYNTHAVERSE Spolka Akcyjna into a list and get an email when it puts out news.

Share price · GPW:SVE

2.60 PLN -0.07 (-2.6%)

Close on Nov 20, 2026

Past year -35.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
2.58 – 2.67 PLNNov 20, 2026
Volume
29,136 sharesNov 20, 2026
Market cap
197.7M PLNAt the close on Nov 20, 2026 · price × 76.02M shares outstanding
52-week range
2.45 – 4.25 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
122,621 PLNMedian day 32,563 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
SYNTHAVERSE Spolka Akcyjna logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
GPW:SVE · Home2.60 PLN-0.07 (-2.6%)29,1362.652.6652.582.67Close on Nov 20, 2026
Frankfurt:6NQ€0.579 EUR-0.013 (-2.2%)—€0.585€0.585€0.579€0.592Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:SVE · PLN, adjusted for splits

DayCloseChange%OpenHighLowVolume
2.60-0.07-2.6%2.652.6652.5829,136
2.67-0.01-0.4%2.692.7652.6743,554
2.68-0.16-5.6%2.852.872.68116,017
2.84+0.19+7.2%2.722.8852.72255,122
2.65-0.05-1.9%2.702.702.6243,343
2.70+0.13+5.1%2.572.7952.55106,838
2.57-0.01-0.4%2.572.582.4547,332
2.58-0.01-0.4%2.562.592.5610,571
2.59+0.01+0.4%2.602.602.56535,211
2.58-0.005-0.2%2.6052.6452.57514,962
2.585-0.025-1.0%2.602.612.5736,416
2.61-0.015-0.6%2.612.6152.5844,780
2.625-0.015-0.6%2.642.642.6236,512
2.64-0.01-0.4%2.6452.6652.63523,476
2.65-0.05-1.9%2.702.732.6073,285
2.70-0.055-2.0%2.752.752.7020,697
2.755-0.005-0.2%2.752.7652.71515,704
2.76+0.04+1.5%2.742.782.72102,995
2.720.000.0%2.722.722.7115,478
2.72+0.01+0.4%2.712.7652.7118,458
2.71-0.07-2.5%2.7852.7952.7127,168
2.780.000.0%2.762.792.7031,621
2.78-0.03-1.1%2.812.832.7439,721
2.81+0.015+0.5%2.8252.832.7441,167
2.795+0.005+0.2%2.802.8352.7738,026
2.79-0.03-1.1%2.8252.8252.7853,688
2.82+0.005+0.2%2.832.832.8033,271
2.815-0.005-0.2%2.8352.842.79541,857
2.820.000.0%2.822.822.8231,467
2.820.000.0%2.822.822.8262,065
2.820.000.0%2.822.822.82110,092
2.820.000.0%2.822.822.8226,022
2.820.000.0%2.822.822.8213,677
2.82+0.005+0.2%2.8152.832.7628,784
2.815-0.035-1.2%2.8252.852.8034,457
2.85-0.03-1.0%2.8952.8952.8329,112
2.88+0.005+0.2%2.902.922.8634,630
2.875-0.015-0.5%2.892.9252.8527,831
2.89+0.02+0.7%2.882.922.8734,799
2.87+0.03+1.1%2.8252.882.8032,047
2.84-0.055-1.9%2.892.892.8030,691
2.895+0.025+0.9%2.902.9252.82535,477
2.87-0.015-0.5%2.852.9152.8247,490
2.885-0.01-0.3%2.8952.922.858,474
2.895+0.005+0.2%2.8652.8952.84510,408
2.89-0.005-0.2%2.902.902.8439,768
2.895+0.025+0.9%2.872.9152.83536,561
2.87-0.06-2.0%2.902.9252.85526,801
2.93-0.025-0.8%2.982.992.9032,986
2.955-0.035-1.2%3.023.032.9321,630
2.99-0.005-0.2%2.9953.012.9510,837
2.995-0.025-0.8%3.023.022.9731,266
3.02+0.07+2.4%2.9753.022.9070,721
2.95+0.015+0.5%2.9352.9752.9222,178
2.935-0.055-1.8%2.952.9852.9061,230
2.99-0.035-1.2%3.033.042.98530,674
3.025-0.015-0.5%3.043.0552.9915,912
3.04+0.02+0.7%3.003.073.0017,456
3.020.000.0%3.043.043.017,260
3.02-0.01-0.3%3.033.0653.0028,707
3.03-0.03-1.0%3.0253.083.02510,891
3.06+0.02+0.7%3.0953.103.02529,248
3.04+0.045+1.5%3.043.112.995202,544
2.995+0.12+4.2%2.8753.012.87596,823
2.875+0.005+0.2%2.872.902.8532,563
Ticker
GPW:SVE
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
GPW
Currency
PLN

What changed lately

Latest news

All SYNTHAVERSE Spolka Akcyjna news

SYNTHAVERSE Spolka Akcyjna on 6ix

Sector
Health care
Industry
Biotechnology
News releases
6 in the last 12 months · 9 in all · newest Jun 29, 2026 · oldest 2025

Where SYNTHAVERSE Spolka Akcyjna is listed

ListingExchangeCountryCurrency
GPW:SVE · Home listing · This pageGPWPolandPLN
LSE:0RKMLSEUnited KingdomPLN
gettex:6NQgettexGermanyEUR
Frankfurt:6NQFrankfurtGermanyEUR
Lang & Schwarz:A1J10ULang & SchwarzGermanyEUR
LS Exchange:A1J10ULS ExchangeGermanyEUR
Munich:6NQMunichGermanyEUR
Stuttgart:6NQStuttgartGermanyEUR

Valuation

EV/sales 5.9× against a median of 28.6×: 2nd lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
288.2M PLN
P/E
Loss
EV/sales
5.9×
EV/EBITDA
Negative EBITDA
Price/book
1.7×
Gross margin
49.6%
Operating margin
−38.9%
Net margin
−43.1%
Debt to equity
0.8×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
SYNTHAVERSE Spolka Akcyjna · GPW:SVEUS$48.68MUS$70.98Mn/a5.9×n/a1.7×−43.1%0.8×n/a
Aldeyra Therapeutics, Inc. · NASDAQ:ALDXUS$50.70MUS$9.72Mn/an/an/a1.4×n/a0.0×0.66
Clene Inc. · NASDAQ:CLNNUS$50.69MUS$58.31Mn/a245×n/an/an/an/a1.48
Aptamer Sciences, Inc. · KRX:291650US$49.50MUS$34.66Mn/a8.6×n/a1.6×−215.8%0.0×n/a
Acrivon Therapeutics, Inc. · NASDAQ:ACRVUS$49.35M−US$26.60Mn/an/an/a0.7×n/a0.0×2.09
Heron Therapeutics, Inc. · NASDAQ:HRTXUS$48.04MUS$156.3Mn/a1.1×n/a9.8×−14.5%26.8×1.93
Helix BioPharma Corp. · TSX:HBPUS$47.94MUS$50.27Mn/an/an/a4.8×n/a0.3×0.36
Oncolytics Biotech Inc. · NASDAQ:ONCYUS$47.66MUS$45.23Mn/an/an/an/an/an/a1.27
THX Pharma · EURONEXT:ALTHXUS$47.23MUS$30.92Mn/an/an/a14.5×n/a0.9×n/a
FluoGuide A/S · OMXSTO:FLUOUS$47.17MUS$43.89Mn/a5,538×n/a10.5×n/a0.9×n/a
Rafael Holdings, Inc. · NYSE:RFLUS$47.10MUS$25.00Mn/a28.6×n/a0.7×n/a0.0×0.92
Median of the othersUS$47.99MUS$39.28M28.6×3.2×−115.2%0.2×1.27

Team and board

Officers

OfficerRole
Artur ChodkowskiCEO
Wiktor NapióraVice-President
Jakub WinklerBoard Member, CLO

Board

DirectorRole
Jarosław Paweł BłaszczakChairman
Dirk PamperinMember of the Supervisory Board
Jakub WinklerBoard Member, CLO
Konrad MiterskiMember of the Supervisory Board
Maciej KornilukMember of the Supervisory Board
Maciej SiedlarMember of the Supervisory Board
Piotr KwaśniewskiMember of the Supervisory Board
Waldemar SierockiMember of the Supervisory Board
Wiktor NapióraVice-President

Events

QuarterResultsShare move
Q2 2026Sep 2, 2026−3.0%
Q1 2026Jun 3, 2026−3.5%
Q4 2025Feb 25, 2026+0.8%
Q3 2025Dec 3, 2025−3.8%
Q2 2025Sep 3, 2025−1.7%
Q1 2025May 29, 2025 · Before open−6.1%
Q4 2024Feb 26, 2025−0.3%
Q3 2024Nov 20, 2024 · Before open+1.4%
Q2 2024Aug 28, 2024+0.2%
Q1 2024May 22, 2024 · After close−0.4%
All 16 quarters
QuarterResultsShare move
Q4 2023Feb 28, 2024−2.1%
Q3 2023Nov 22, 2023 · After close−2.0%
Q2 2023Sep 21, 2023−1.7%
Q1 2023May 31, 2023−2.8%
Q4 2022Mar 1, 2023−0.5%
Q3 2022Nov 30, 2022−11.0%

Open Events

Financials

Annual, in PLN

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue42.0M71.8M58.6M50.4M41.2M40.2M39.1M32.3M31.4M36.3M
Cost of revenue29.0M27.5M23.4M22.4M18.5M19.6M17.9M16.1M17.4M23.0M
Gross profit13.0M44.3M35.2M28.5M22.7M20.6M21.3M16.2M14.0M13.3M
Research and development6.00K15.0K2.42M2.10M
Selling, general and administrative31.0M24.8M18.2M12.7M12.3M13.9M11.4M11.9M12.9M11.8M
Operating income-20.6M12.4M8.65M9.84M7.19M5.93M5.72M-35.4M4.85M-27.8M
Depreciation and amortization13.3M8.09M6.63M6.22M6.54M5.83M5.83M6.07M6.34M3.92M
EBITDA-7.28M20.5M15.3M16.1M13.7M11.8M11.6M-29.4M11.2M-23.9M
Interest expense3.95M3.10M1.69M836.0K1.28M1.65M2.02M2.66M3.96M3.69M
Income before tax-23.9M9.64M6.57M8.35M5.89M4.31M3.72M-38.2M1.68M-30.8M
Income tax-3.98M2.09M1.81M2.27M1.64M-126.0K1.24M-5.81M1.09M-7.31M
Net income-19.9M7.55M4.76M6.08M4.25M4.44M2.48M-32.4M588.0K-23.5M
Earnings per share, basic-0.270.110.070.090.070.070.04-0.540.01-0.53

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.67M760.0K2.17M27.1M14.3M1.84M660.0K58.0K2.32M672.0K
Short-term investments56.0K5.17M-147.0K5.68M
Receivables22.7M35.7M20.3M15.1M11.6M10.5M4.83M6.51M8.16M
Inventory12.3M9.72M15.5M12.7M9.32M9.10M8.63M6.94M9.32M10.7M
Current assets121.9M46.2M45.6M55.4M40.8M22.0M14.8M14.3M21.8M25.5M
Goodwill000
Total assets304.1M298.6M265.9M163.1M116.8M85.9M81.1M86.3M121.0M112.7M
Accounts payable2.17M16.9M2.88M2.78M1.77M2.29M3.30M2.75M2.69M3.63M
Current liabilities135.0M43.0M31.0M24.5M17.2M24.6M20.3M22.3M26.0M68.8M
Long-term debt58.2M58.9M5.98M1.79M
Total debt84.6M80.4M70.0M15.1M6.49M13.3M9.57M12.7M13.9M63.3M
Total liabilities139.4M177.2M153.3M57.5M42.3M48.6M48.2M55.9M63.2M111.5M
Shareholders' equity124.7M121.5M112.6M105.6M74.6M37.3M32.9M30.4M57.8M1.13M
Shares outstanding72.6M70.5M70.3M65.4M63.1M62.3M62.3M60.6M57.5M44.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations7.22M13.7M-5.34M2.95M-3.28M343.0K8.16M-620.0K4.36M15.8M
Capital spending-28.0M-41.8M-112.6M-36.8M-18.4M-2.02M-806.0K-2.64M-484.0K-5.01M
Free cash flow-20.8M-28.1M-117.9M-33.8M-21.7M-1.68M7.35M-3.26M3.87M10.8M
Cash from investing-27.8M-25.9M-72.9M-27.0M-4.49M-2.02M-690.0K-2.64M5.34M-4.77M
Cash from financing21.5M10.7M53.3M36.8M20.2M2.86M-6.87M1.00M-8.05M-10.4M
Dividends paid-2.22M
Change in cash913.0K-1.42M-24.9M12.8M12.5M1.18M602.0K-2.26M1.65M619.0K

Open Financials

Cap table

Built by 6ix from SYNTHAVERSE Spolka Akcyjna’s releases

Common shares
76,019,403
Fully diluted
76,019,403

Fully diluted

LineShares
Common shares76,019,403

Share count over time

CountShares
Nov 22, 202676,019,403

Open Cap table

Shareholders

HolderSharesValueAs of
State Street(R) SPDR(R) Portfolio Europe ETF1,173US$908Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Artur ChodkowskiCEO · Since at least Jan 14, 2026
Dirk PamperinMember of the Supervisory Board · Since at least Nov 5, 2026
Jakub WinklerBoard Member, CLO · Since at least Nov 5, 2026
Jarosław Paweł BłaszczakChairman · Since at least Nov 5, 2026
Konrad MiterskiMember of the Supervisory Board · Since at least Nov 5, 2026
Maciej KornilukMember of the Supervisory Board · Since at least Nov 5, 2026
Maciej SiedlarMember of the Supervisory Board · Since at least Nov 5, 2026
Piotr KwaśniewskiMember of the Supervisory Board · Since at least Nov 5, 2026
Waldemar SierockiMember of the Supervisory Board · Since at least Nov 5, 2026
Wiktor NapióraVice-President · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about SYNTHAVERSE Spolka Akcyjna.